CIP
WGS icon

Chartwell Investment Partners’s GeneDx Holdings WGS Stock Holding History

Chartwell Investment Partners’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.72M Buy
+40,573
New +$1.37M 0.06% 303

Other funds holding WGS

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

Chartwell Investment Partners's WGS Position: Q3 2024 in Review

Chartwell Investment Partners opened a new position in GeneDx Holdings (WGS) in Q3 2024: 40,573 shares worth $1.72M. The stake represents 0.06% of the portfolio and ranks #303 among its holdings.

136 funds tracked by Wall St. Rank hold WGS as of Q3 2024.

  • Chartwell Investment Partners held 40,573 shares of GeneDx Holdings worth $1.72M as of Q3 2024.
  • GeneDx Holdings was a new Chartwell Investment Partners position in Q3 2024.
  • GeneDx Holdings made up 0.06% of Chartwell Investment Partners's portfolio in Q3 2024, its #303 holding.
  • 136 funds tracked by Wall St. Rank held GeneDx Holdings as of Q3 2024.

Based on Chartwell Investment Partners's 13F filing for Q3 2024, filed 4 Nov 2024.